Today: 29 April 2026
HSBC share price slips in early London trade as BoE call, mortgage repricing grab attention
5 February 2026
2 mins read

HSBC share price slips in early London trade as BoE call, mortgage repricing grab attention

London, Feb 5, 2026, 08:02 GMT — Regular session

Shares of HSBC Holdings Plc slipped 0.6% to 1,300.2 pence in early London trading on Thursday, pulling back slightly from this week’s rally after opening at 1,302 pence. So far, the stock has fluctuated between 1,297.2 and 1,304.1 pence, with light volume early in the session.

The market pullback coincides with renewed attention on rate decisions, especially the Bank of England’s announcement later Thursday. This move is critical for UK lenders, affecting both margins and loan demand. Economists surveyed by Reuters predict the BoE will keep the Bank Rate steady at 3.75%, while investors generally expect the next rate cut to come in the second quarter.

Mortgage pricing is shifting as well, with HSBC among the major players adjusting rates this week. Nicholas Mendes, mortgage technical manager at John Charcol, noted that “Fixed mortgage rates are influenced less by the base rate decision on the day, and more by what is happening in swap rates,” pointing to the market rates lenders rely on to gauge longer-term funding costs. Mortgage Professional

Trade press reports that HSBC will raise rates on several two- and five-year fixed mortgage products starting Feb. 4. The hikes affect deals for first-time buyers, home movers, remortgagers, and certain offers linked to energy-efficient properties. Multiple loan-to-value bands are impacted, with rates generally climbing as deposits shrink.

HSBC closed Wednesday 0.5% higher at 1,307.6 pence, staying close to its 52-week peak of 1,320.4 pence. With little driving momentum, the shares look vulnerable to some profit-taking. As a major player in London’s blue-chip index, even modest shifts in HSBC’s price can impact the broader market.

Bank shares slid across Europe Wednesday, despite the broader STOXX 600 hitting a record high. UBS warned of more challenges ahead in U.S. wealth management, while Santander revealed a $12.2 billion purchase of Webster Financial, a U.S. regional lender. The bank sub-index dropped 1.2% on the session.

HSBC popped up in deal activity overnight as one of the placing agents and managers for Tianqi Lithium’s effort to raise roughly HK$5.86 billion via share placement and convertible bonds. It’s a modest mandate for HSBC’s massive balance sheet, but it helps the bank stay active in the Asian equity-linked pipeline it’s been relying on.

Currency swings are complicating matters. Sterling climbed to a new five-month peak against the euro on Wednesday, driven by MUFG’s Lee Hardman citing “a reduction in UK fiscal and political risks” following the budget and hints of stronger growth momentum. But a firmer pound also cuts into the value of overseas earnings when converted back to sterling. Reuters

In Europe, the European Central Bank looks set to hold rates steady, signaling no immediate changes despite the euro’s recent rally versus the dollar. TS Lombard’s Davide Oneglia cautioned against overinterpreting the situation, pointing to the ECB’s focus on activity, wages, and lending figures.

Markets remain volatile, with UK stocks caught up in sector rotations and wild swings in “AI-exposed” shares this week. “Risk appetite just isn’t fully restored,” said Ipek Ozkardeskaya, senior analyst at Swissquote Bank, commenting on Tuesday’s London trading session. Reuters

HSBC investors are now looking ahead to two key events: the Bank of England’s decision later Thursday and the bank’s annual results due Feb. 25. That’s when HSBC will provide updates on capital returns, plus its income and cost outlook.

Stock Market Today

  • April FOMC US Index Levels Update: Dow Jones, Nasdaq, S&P 500
    April 29, 2026, 1:36 PM EDT. Stocks face volatility ahead of key earnings reports from tech giants Meta, Alphabet, Amazon, and Microsoft after market close. Investors seek signs that massive infrastructure spending and AI investments, fueled by trillions of dollars, are generating expected returns. This scrutiny recalls the 2025 AI/Tech crash triggered by unmet high expectations. Meanwhile, geopolitical tensions persist as the US-Iran standoff affects the Strait of Hormuz, pushing oil prices above $105 per barrel. Elevated crude prices raise concerns over inflation and market stability. The market waits on April FOMC signals and intraday performance metrics for the Dow Jones, Nasdaq, and S&P 500 to gauge risk appetite amid these economic and geopolitical pressures.

Latest article

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

29 April 2026
The Dow Jones Industrial Average dropped 320 points, or 0.65%, to 48,821.82 Wednesday afternoon, heading for a fifth straight loss as investors awaited the Federal Reserve’s rate decision and major tech earnings. Brent crude surged 7.14% to $119.20 after reports of a possible extended Iran blockade. Boeing and Goldman Sachs weighed on the Dow, while Amazon rose and Microsoft slipped in midday trading.
General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Singtel stock price slips after KKR’s $5.2 billion STT GDC deal — here’s what’s driving it
Previous Story

Singtel stock price slips after KKR’s $5.2 billion STT GDC deal — here’s what’s driving it

BAE Systems share price slides as buyback update lands and investors eye Feb 18 results
Next Story

BAE Systems share price slides as buyback update lands and investors eye Feb 18 results

Go toTop